Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMXI-5001 in Advanced Malignancies
NCT04503265Phase 2Recruiting
- Sponsor
- AtlasMedx
- Start
- Aug 2020
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amxi-5001 in cancer, breast cancer, ovarian cancer, prostate cancer (PCa), pancreatic cancer (PC), sponsored by AtlasMedx. Started Aug 2020; status: recruiting.
02
Drugs
amxi-5001
03
Conditions
cancerbreast cancerovarian cancerprostate cancer (PCa)pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04503265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04503265.